Skip to content
Advancing Management of Allergic Rhinitis in the Pediatric Care Setting: The Role of Oral Tablet Immunotherapy Evaluation (ID: c903-2)
*
1.
Which of the following best describes your profession?
(Required.)
MD/DO
PA
NP
RN
PharmD/RPh
Other (please specify)
*
2.
Which of the following best describes your specialty?
(Required.)
Pediatrics
Family Practice/Internal Medicine
Allergy
Other (please specify)
*
3.
How many patients with AR/C do you see in a typical week?
(Required.)
1 to 10
11 to 25
26 to 50
More than 50
0
*
4.
How many years have you been in practice?
(Required.)
<1
1 to 10
11 to 20
>20
*
5.
Which of the following best describes your practice setting?
(Required.)
Academic medical center
Community hospital
Group practice
Private practice
VA/DOD/Government
Other (please specify)
*
6.
After participating in this activity, how confident are you in the management of patients with AR/C in your practice?
(Required.)
Very confident
Confident
Little confidence
No confidence
*
7.
Please rate your level of agreement by checking the appropriate rating. The educational activity:
(Required.)
Strongly agree
Agree
Disagree
Strongly disagree
Met the stated learning objectives
Strongly agree
Agree
Disagree
Strongly disagree
Enhanced my current knowledge base
Strongly agree
Agree
Disagree
Strongly disagree
Addressed my most pressing questions
Strongly agree
Agree
Disagree
Strongly disagree
Promoted improvements or quality in healthcare
Strongly agree
Agree
Disagree
Strongly disagree
Was scientifically rigorous and evidence based
Strongly agree
Agree
Disagree
Strongly disagree
Was effectively delivered by faculty
Strongly agree
Agree
Disagree
Strongly disagree
Avoided commercial bias or influence
Strongly agree
Agree
Disagree
Strongly disagree
*
8.
Which of the following best describes the impact of this activity on your performance?
(Required.)
I gained new strategies/skills/information I will apply to my area of practice
I need more information before I can change my practice
My practice is already consistent with the information presented
This activity will not change my practice
*
9.
How committed are you to making changes in your practice based on your participation in this activity?
(Required.)
Very committed
Committed
Not committed
I do not plan to make changes
If not committed or do not plan to make changes, please indicate reason.
*
10.
Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.
(Required.)
Increased knowledge of the burden and impact of AR/C in child and adolescent patients
Improved ability to assess pediatric patients with AR/C
Better understanding of the role of skin prick and sIgE testing in patient assessment
Recognition of unmet needs in the care of children and adolescents with AR/C
Increased knowledge of the role of AIT in AR/C
Improved ability to differentiate between SCIT and sublingual tablet immunotherapy
Awareness of current FDA approval status of immunotherapies for patients with AR/C
Ability to develop treatment plans that appropriately incorporate sublingual tablet immunotherapy for patients who are suitable candidates
Other (please specify)
*
11.
What barriers do you see to making changes in your practice? Please select all that apply.
(Required.)
Lack of knowledge regarding evidence-based strategies
Lack of convincing evidence to warrant change
Lack of time/resources to consider change
Insurance, reimbursement, or legal issues
Conflicting guidelines or evidence
Patient compliance and/or patient resource barriers
Other (please specify)
12.
As a result of your participation in this activity, what is one change you are most likely to implement in your practice?
13.
Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for AR/C or related disease states:
14.
If you indicated that you perceived commercial bias or influence, please describe:
